Clinical Trials on Urinary Bladder, Overactive

Total 60873 results

Walter Reed National Military Medical Center

Recruiting

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

Overactive Bladder Syndrome

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

Comparison and Evaluation of USSQ, OABSS, and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral D-J Stents in Patients Who Underwent URL

Urolithiasis | Overactive Bladder Syndrome

China
University Hospital, Ghent
Astellas Pharma Inc; Medtronic

Completed

Treatment of the Overactive Bladder Syndrome: A Delphi Study

Overactive Bladder Syndrome

Belgium
University Hospital, Ghent

Terminated

TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I) (TaPaS)

Overactive Bladder Syndrome

Belgium
Stimvia s.r.o.

Completed

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

Overactive Bladder (OAB) | Failed Any OAB Pharmacotherapy

Czechia
Chung Shan Medical University

Unknown

Efficacy of Different Electrical Stimulation Placement in Patients With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Taiwan
Far Eastern Memorial Hospital

Completed

Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

Overactive Bladder Syndrome

Taiwan
Salvat

Completed

SVT-40776 in Patients Suffering From Overactive Bladder Syndrome

Overactive Bladder (OAB)
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

United States
Hospital Italiano de Buenos Aires

Recruiting

Virtual Bladder Training for Overactive Bladder Syndrome in Women. Which Symptom Responds Better?

Overactive Bladder Syndrome

Argentina
Centre Hospitalier de Roubaix

Not yet recruiting

Effectiveness of HYPNOsis Masks During Botulinum TOXin Injections in Idiopathic Overactive Bladder(HypnoTox) (HypnoTox)

Idiopathic Overactive Bladder
Far Eastern Memorial Hospital

Recruiting

Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Taiwan
Far Eastern Memorial Hospital

Recruiting

Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing

Overactive Bladder Syndrome

Taiwan
Astellas Pharma Global Development, Inc.

Completed

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) (PILLAR)

Overactive Bladder (OAB)

United States, Canada
Maastricht University Medical Center
University Hospital, Antwerp; Zuyderland Hospital

Unknown

Experience Sampling Method in OAB Patients

Overactive Bladder | Overactive Bladder Syndrome

Netherlands
University of Sao Paulo General Hospital

Completed

Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment (OAB)

Overactive Bladder Syndrome

Brazil
Far Eastern Memorial Hospital

Withdrawn

Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Taiwan
University of Sao Paulo General Hospital

Completed

Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome

Overactive Bladder Syndrome

Brazil
Federal University of São Paulo

Unknown

Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome

Overactive Bladder Syndrome
Maastricht University Medical Center

Unknown

The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome

Overactive Bladder Syndrome

Netherlands
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder (OAB)

Japan
NHS Greater Glasgow and Clyde
Glasgow Caledonian University; University of Glasgow

Unknown

TPTNS: Home vs Hospital Treatment for Overactive Bladder

Overactive Bladder | Detrusor, Overactive

United Kingdom
Universiteit Antwerpen

Unknown

Sacral Neuromodulation and Pudendal Somatic Afferents

Overactive Bladder, Non Obstructive Urinary Retention

Belgium
Pamukkale University

Recruiting

Tibial Nerve and Extracorporeal Magnetic Stimulation for Overactive Bladder

Idiopathic Overactive Bladder | Bladder Training | Transcutaneous Tibial Nerve Stimulation | Magnetic Stimulation

Turkey
Taipei Veterans General Hospital, Taiwan

Recruiting

Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial

Overactive Bladder Syndrome

Taiwan
Buddhist Tzu Chi General Hospital

Unknown

Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

Overactive Bladder Syndrome

Taiwan
Radboud University Medical Center

Withdrawn

Overactive Bladder (OAB) Drink Advice Study

Overactive Bladder Syndrome

Netherlands
Pfizer

Completed

Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
Pfizer

Completed

A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

Overactive Bladder Syndrome

Germany
Astellas Pharma Europe Ltd.

Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice (BELIEVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder Overactive

Czechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
Sunovion
PPD; ICON Clinical Research; Covance; Dainippon Sumitomo Pharma America; ClinPhone...

Completed

SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)

Overactive Bladder Syndrome (OABS)

France, United Kingdom, United States, Estonia, Germany, Latvia, Lithuania, Poland, Spain
Hospital Universitário Professor Edgard Santos

Unknown

A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder

Overactive Bladder Associated With HTLV-1

Brazil
Maastricht University Medical Center

Completed

Effect of Pulse Rate Changes on Clinical Outcome

Overactive Bladder Syndrome | Chronic Urinary Retention

Netherlands
University of Zurich

Completed

Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms

Overactive Bladder Syndrome

Switzerland
William Beaumont Hospitals

Terminated

OnabotulinumtoxinA Bladder Injection Study

Overactive Bladder | Urinary Bladder, Overactive | Urinary Incontinence | Overactive Bladder Syndrome | Urinary Urgency | Urinary Frequency/Urgency

United States
Centre Hospitalier Universitaire Dijon

Unknown

Retrospective Study of Prescribed Physical Activity in Patients With Overactive Bladder Syndrome Monitored Within the Pelvi-perineology Network in Dijon: Evaluation of Prescription Compliance and Impact on Quality of Life (HAV-AP)

iOAB= Idiopathic Overactive Bladder

France
Pfizer

Completed

This Is A Study Of Bioavailability And Food Effect For Fesoterodine.

Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency

United States
University Of Perugia

Unknown

Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin

Overactive Bladder Syndrome

Italy
National Taiwan University Hospital

Completed

Predictors for Retreatement of OAB After DC Mirabegron

Recurrence of Overactive Bladder Syndrome

Taiwan
Duke University

Recruiting

Yoga for Treatment of Overactive Bladder in Pediatric Patients

Overactive Bladder | Overactive Detrusor | Overactive Bladder Syndrome

United States
Astellas Pharma China, Inc.

Completed

A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder

Urge Incontinence | Overactive Bladder (OAB)

China
Astellas Pharma Inc

Terminated

A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)

Bladder Function

United States
Michael Chancellor, MD
William Beaumont Hospitals

Completed

Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.

Overactive Bladder

United States
Takeda

Completed

Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome

Overactive Bladder Syndrome
Ankara Yildirim Beyazıt University

Not yet recruiting

Comparison of the Effects of External Electrical Stimulation Protocols in Women With Overactive Bladder

Overactive Bladder
The Methodist Hospital Research Institute

Recruiting

Procedural Discomfort Related to Number of Intradetrusor Botox Injections (BIND)

Overactive Bladder

United States
Peking Union Medical College Hospital

Not yet recruiting

Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study

Overactive Bladder
Cedars-Sinai Medical Center

Recruiting

The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder

Overactive Bladder

United States
Axonics Modulation Technologies, Inc.

Completed

Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) (RELAX-OAB)

Overactive Bladder

Netherlands, France, Belgium, United Kingdom
Hugel

Completed

Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder

Overactive Bladder

Korea, Republic of

Clinical Trials on Urinary Bladder, Overactive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations